(1R,2R)-2-Chlorocarbonyl-cyclopropanecarboxylic acid ethyl ester

• 分子结构分类: 有机化合物 - 有机酸及其衍生物 - 羧酸及其衍生物
• 英文名称: (1R,2R)-2-Chlorocarbonyl-cyclopropanecarboxylic acid ethyl ester
• 英文别名: ethyl (1R,2R)-2-carbonochloridoylcyclopropane-1-carboxylate
• 化学式: C₇H₉ClO₃
• 分子量: 176.6
• InChiKey: NTNBNHCYSBPWGE-RFZPGFLSSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  1.1
• 重原子数：
  11
• 可旋转键数：
  4
• 环数：
  1.0
• sp3杂化的碳原子比例：
  0.71
• 拓扑面积：
  43.4
• 氢给体数：
  0
• 氢受体数：
  3

反应信息

• 作为反应物：
  描述：

  (1R,2R)-2-Chlorocarbonyl-cyclopropanecarboxylic acid ethyl ester 在 sodium hydroxide 、 四(三苯基膦)钯 、 铜 、 锌 作用下， 以 乙醇 为溶剂， 生成 (1R,2R)-2-propanoylcyclopropane-1-carboxylic acid
  参考文献：
  名称：

  2-Substituted (2SR)-2-Amino-2-((1SR,2SR)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 1. Effects of Alkyl, Arylalkyl, and Diarylalkyl Substitution

  摘要：

  In this paper, we describe the synthesis of a series of a-substituted analogues of the potent and selective group II metabotropic glutamate receptor (mGluR) agonist (1S,1'S,2'S)-carboxy-cyclopropylglycine (2, L-CCG 1). Incorporation of a substituent on the amino acid carbon converted the agonist 2 into antagonist. Ail of the compounds were prepared and tested as a series of four isomers, i.e., two racemic diastereomers. We explored alkyl substitution, both normal and terminally branched; phenylalkyl and diphenylalkyl substitution; and a variety of aromatic and carbocyclic surrogates for phenyl. Affinity for group II mGluRs was measured using [H-3]glutamic acid (Glu) binding in rat forebrain membranes. Antagonist activity was confirmed for these compounds by measuring their ability to antagonize (1S,3R)-1-aminocyclopentane-1,3-dicarboxylic acid-induced inhibition of forskolin-stimulated cyclic-AMP in RGT cells transfected with human mGluR2 and mGluR3. We found that while alkyl substitution provided no increase in affinity relative to 2, phenylethyl and diphenylethyl substitution, as in 105 and 109, respectively, were quite beneficial, The affinity of 109 was further enhanced when the two aromatic rings were joined by an oxygen or sulfur atom to form the tricyclic xanthylmethyl and thioxanthylmethyl amino acids 113 and 114, respectively. Amino acid 113, with an IC50 of 0.10 mu M in the [H-3]Glu binding assay, was 52-fold more patent than 2, whose IC50 was 0.47 mu M.

  DOI：

  10.1021/jm970497w
• 作为产物：
  描述：

  反-1,2-环丙烷二羧酸二乙酯 在 草酰氯 、 N,N-二甲基甲酰胺 、 sodium hydroxide 作用下， 以 四氢呋喃 、 乙醇 、 水 为溶剂， 反应 12.08h， 生成 (1R,2R)-2-Chlorocarbonyl-cyclopropanecarboxylic acid ethyl ester
  参考文献：
  名称：

  （±）-反式-环丙烷-1,2-二羧酸†衍生的酰胺酯和二酰胺的对映选择性细菌水解作用†

  摘要：

  由可商购获得的（±）-反式-环丙烷-1，2-二羧酸二乙酯制备衍生自反式-环丙烷-1，2-二羧酸的不同光学活性的酰胺基酯，混合酸酯，酰胺酸和二酰胺。关键步骤是杜鹃红球菌IFO 15564催化水解相应的外消旋酰胺。该微生物中存在的酰胺酶对这些底物表现出中等至高的对映选择性。另外，一些酶法制备的环丙烷羧酸的简单有效的库尔修斯重排使我们能够以高收率和对映体过量获得旋光性β-氨基环丙烷羧酸衍生物。

  DOI：

  10.1039/c3ob42066c

文献信息

• Cyclopropylindole derivatives as selective serotonin reuptake inhibitors
  申请人：——

  公开号：US20030073849A1

  公开（公告）日：2003-04-17

  The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulations comprising said compounds 1 useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.

  本发明涉及式(I)的化合物及其药学上可接受的盐或溶剂和包含该化合物的药学上可接受的配方，用于治疗抑郁症、焦虑障碍、早泄、慢性疼痛、强迫症、进食障碍、经前期失调障碍、恐慌障碍以及包括双相情感障碍和精神分裂症在内的精神障碍。
• 2-Substituted (2<i>SR</i>)-2-Amino-2-((1<i>SR</i>,2<i>SR</i>)-2-carboxycycloprop-1-yl)glycines as Potent and Selective Antagonists of Group II Metabotropic Glutamate Receptors. 2. Effects of Aromatic Substitution, Pharmacological Characterization, and Bioavailability
  作者：Paul L. Ornstein、Thomas J. Bleisch、M. Brian Arnold、Joseph H. Kennedy、Rebecca A. Wright、Bryan G. Johnson、Joseph P. Tizzano、David R. Helton、Mary Jeanne Kallman、Darryle D. Schoepp、Marc Hérin

  DOI：10.1021/jm970498o

  日期：1998.1.1

  5-fold increases in affinity. Substitution with p-fluorine, as in 97 (IC50 = 0.022 +/- 0.002), was the exception. Here, a greater increase in affinity was realized than for either the ortho- or meta-substituted analogues; 97 was the most potent compound resulting from monosubstitution of the aromatic. At best, only modest increases in affinity were realized for certain compounds bearing either two chlorines

  在本文中，我们描述了一系列有效的和选择性的II型代谢型谷氨酸受体（mGluR）激动剂（1S，1'S，2'S）-羧基环丙基甘氨酸（2，L-CCG 1）的一系列α-取代类似物的合成。在氨基酸碳上引入取代基将激动剂2转化为拮抗剂。所有化合物均已制备并测试为一系列四个异构体，即两个外消旋非对映异构体。基于对α-苯乙基类似物3亲和力的改善，在本文中，我们探讨了取代对芳环的影响，作为增加与这些化合物对II型mGluRs的亲和力的策略。II组mGluRs的亲和力是使用[3H]谷氨酸（Glu）在大鼠前脑膜中的结合来测量的。通过测量它们在人类mGluR2和mGluR3转染的RGT细胞中拮抗（1S，3R）-1-氨基环戊烷-1,3-二羧酸诱导的福司柯林刺激的环-AMP抑制作用的能力，证实了它们的拮抗活性。3的芳香环上的间位取代基由各种取代基提供，这些取代基分别是给电子（例如甲基，羟基，氨基，甲氧基，苯基，苯氧基
• Synthesis of γ-aminobutyric acid analogues of restricted conformation. Part 2. The 2-(aminomethyl)cycloalkanecarboxylic acids
  作者：Peter D. Kennewell、Saroop S. Matharu、John B. Taylor、Robert Westwood、Peter G. Sammes

  DOI：10.1039/p19820002563

  日期：——

  The syntheses of analogues with restricted rotation about the C(2)–C(3) bond of γ-aminobutyric acid, namely cisand trans-2-(aminomethyl)-cyclopropane and -cyclobutanecarboxylic acids and trans-2-(aminomethyl)cyclohexanecarboxylic acid are described.

  绕γ-氨基丁酸的C（2）–C（3）键旋转受限的类似物的合成，即顺式和反式-2-（氨基甲基）-环丙烷和-环丁烷羧酸和反式-2-（氨基甲基）环己烷羧酸被描述。
• Synthesis and Structure–Activity Relationship Studies of Novel 2-Diarylethyl Substituted (2-Carboxycycloprop-1-yl)glycines as High-Affinity Group II Metabotropic Glutamate Receptor Ligands
  作者：Ulrik S Sørensen、Thomas J Bleisch、Anne E Kingston、Rebecca A Wright、Bryan G Johnson、Darryle D Schoepp、Paul L Ornstein

  DOI：10.1016/s0968-0896(02)00387-5

  日期：2003.1

  (L-CCG-1) is a potent agonist at, primarily, group II metabotropic glutamate receptors, alkylation of at the alpha-carbon notoriously result in group II mGluR antagonists, of which the most potent compound described so far, LY341495, displays IC(50) values of 23 and 10 nM at the group II receptor subtypes mGlu2 and mGlu3, respectively. In this study we synthesized a series of structural analogues of

  中枢神经系统中的主要兴奋性神经递质（S）-谷氨酸可激活离子型和代谢型兴奋性氨基酸受体。它与神经系统疾病和精神疾病有关的重要性已将极大的注意力转移到调节该内源性配体作用的化合物的开发上。鉴于L-羧环丙基甘氨酸（L-CCG-1）主要是针对II型代谢型谷氨酸受体的有效激动剂，而众所周知，α-碳上的L-羧环丙基甘氨酸烷基化会导致II型mGluR拮抗剂，迄今为止，该化合物是最有效的化合物， LY341495在II组受体亚型mGlu2和mGlu3上分别显示23（nM）和10 nM的IC（50）值。在这项研究中，我们合成了一系列的结构类似物，其中的黄嘌呤部分被两个取代的苯基取代。药理学特征表明，当测试它们的外消旋物时，这些新型化合物对II组mGluR具有很高的亲和力。最有效的类似物显示出K（i）值在5-12 nM范围内，因此可与LY341495相比。
• [EN] CYCLOPROPYLINDOLE DERIVATIVES AS SELECTIVE SEROTONIN REUPTAKE INHIBITORS<br/>[FR] DERIVES DE CYCLOPROPYLINDOLE UTILISES EN TANT QU'INHIBITEURS SELECTIFS DE RECAPTAGE DE LA SEROTONINE
  申请人：BRISTOL MYERS SQUIBB CO

  公开号：WO2002079152A1

  公开（公告）日：2002-10-10

  The present invention relates to compounds of Formula (I) and pharmaceutically acceptable salts or solvates thereof and pharmaceutically acceptable formulaitons comprising said compounds useful for the treatment of depression, anxiety disorders, premature ejaculation, chronic pain, obsessive-compulsive disorder, feeding disorders, premenstrual dysphoric disorder, panic disorders and psychotic disorders including bipolar disorder and schizophrenia.

  本发明涉及式(I)的化合物及其药学上可接受的盐或溶剂，以及包含所述化合物的药学上可接受的制剂，用于治疗抑郁症、焦虑症、早泄、慢性疼痛、强迫症、进食障碍、月经前紧张症、恐慌症和包括双相情感障碍和精神分裂症在内的精神障碍。